Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2026 · 10-Q
Revenue$848.90M$848.90M+2.7% vs Q2 2025 Net Income-$15.00M-$15.00MN/M vs Q2 2025 EPS Diluted-$0.12-$0.12N/M vs Q2 2025 Operating Income$102,100,000−8.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$37,500,000−35.2% Margins · derivedOperating margin12.0%−1.5 pt vs Q2 2025
Net margin-1.8%−1.5 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end